A Study to Evaluate the Use of a Novel Wearable Device for Temperature Monitoring in Cancer Patients Who Underwent Autologous Stem Cell Transplant


About this study

The purpose of this study is to evaluate the performance of the wearable tPatch device when compared to an oral temperature measuring device in patients who have undergone a post-autologous bone marrow transplant.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Subjects at least 18 years of age
  2. Subjects able to read, understand, and complete the informed consent form
  3. Subjects treated for cancer and scheduled to undergo autologous stem cell transplant at Mayo Clinic, Rochester, MN
  4. Subjects able to wear wearable temperature sensing device(s) for the duration of the study
  5. Subjects able to record body temperature per the protocol for the duration of the study

Exclusion Criteria:

  1. Subjects pregnant or breastfeeding
  2. Subjects with leukemia
  3. Subjects diagnosed with renal failure based on estimated glomerular filtration rate (eGFR) for age, size, gender and race norms
  4. Subjects with ECOG performance status of 2 and greater
  5. Subjects with known allergies to medical grade adhesives
  6. Subjects with known cutaneous hypersensitivity
  7. Subjects with impaired decision-making capabilities
  8. Subjects with wireless medical devices or implantable electronic medical devices (e.g., pacemakers, implantable defibrillators, and spinal stimulators)
  9. Subjects febrile at time of enrollment or placement of the tPatch device
  10. Any additional condition or situation that, in the opinion of the Investigator, makes the subject inappropriate for participation in the study

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Svetomir Markovic, M.D., Ph.D.

Closed for enrollment

More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions